Kazia Therapeutics Limited (NASDAQ:KZIA – Get Rating) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 141,400 shares, a growth of 10.0% from the March 15th total of 128,600 shares. Based on an average daily trading volume, of 53,000 shares, the short-interest ratio […]
Kazia Therapeutics Limited (ASX:KZA – Get Rating) insider Bryce Carmine purchased 135,000 shares of the firm’s stock in a transaction on Monday, March 13th. The stock was bought at an average cost of A$0.12 ($0.08) per share, with a total value of A$16,200.00 ($10,872.48). Bryce Carmine also recently made the following trade(s): On Friday, March […]
Kazia Therapeutics Limited (ASX:KZA – Get Rating) insider Steven Coffey purchased 135,000 shares of the firm’s stock in a transaction that occurred on Monday, March 20th. The stock was purchased at an average price of A$0.12 ($0.08) per share, with a total value of A$16,200.00 ($10,872.48). Kazia Therapeutics Price Performance The company has a debt-to-equity […]